Medication Reconciliation at the Indian OPD Intake Desk
Compare medicine strips, discharge papers and reported use with a three-source case, Hindi intake question and discrepancy handover.
An IFA or deworming record should reconcile the programme plan, the actual product and what the person has already received or taken. School, anganwadi, antenatal and private-clinic records can describe the same course differently. Confirm the applicable age or pregnancy context and current guidance before creating a calendar. A preventive programme entry is not automatically an individual treatment prescription.
Indian paediatric, general-practice and antenatal teams reconciling iron–folic acid and deworming information across public programmes, households and private care.
A parent may bring a school message, a bottle from an anganwadi and a prescription issued after a blood test. All three can mention iron, but they do not necessarily represent three additional courses. Start by asking who issued each instruction, why it was issued and whether the receiving clinician intended it to replace or supplement another plan.
Use separate labels for preventive programme supply, an individual clinician's treatment plan and a historical dose. This distinction changes the next action. Programme participation calls for record reconciliation; a new treatment decision requires clinical assessment. Neither a receipt nor a calendar entry establishes that a dose was taken.
NHM's official Anaemia Mukt Bharat directory now lists operational guidelines for 2026 alongside older documents. Identify the version and the relevant beneficiary group when reviewing an existing clinic reference card. This article does not reproduce the new dosing schedules, and the 2026 document has not been fully reviewed here.
Avoid a single default called 'standard IFA schedule'. Age, pregnancy context, formulation and the reason for use need to be resolved before a responsible clinician adopts instructions. A familiar tablet colour or a previous school campaign cannot answer all four questions.
Record the printed product name, ingredients, strength and dosage form from a legible pack or authoritative supply record. Preserve whether iron content is described as elemental iron or as the mass of an iron compound. These labels are not interchangeable numbers, and staff should not convert an unclear description into a dose.
For liquids, record the labelled concentration and the prescribed volume as separate fields. For tablets, keep tablet strength separate from tablets per administration. The same brand family or colour can appear in different presentations. A photographed front panel may omit the information needed to identify the formulation.
Ask the patient or caregiver to bring the actual container when practical. If a strip has been cut and the identity is missing, record that limitation and seek confirmation. 'Red tablet from school' is useful history, but it should remain a reported description until the product is established.
Include other supplements in the history, particularly when a pregnancy or child-health visit involves several providers. The purpose is to show the clinician possible overlap, not to tell the patient to stop or combine medicines independently.
On a narrow screen, scroll the table horizontally to read all columns.
| Evidence | What it can establish | What still needs confirmation |
|---|---|---|
| Programme card | Named scheme, recorded product and dated supply | Whether the person received or took it |
| Current prescription | Authorised instructions and stated purpose | Actual start, changes and other sources |
| Labelled pack | Identity, strength, form and expiry details | Whether it belongs to this person and plan |
| Caregiver account | Reported use and difficulties | Unclear names, dates and quantities |
| Clinic reconciliation note | Current decision and unresolved questions | Whether the resulting plan was understood |
Use a dated sequence: issued, started, reportedly taken, interrupted, changed and reviewed. Record who supplied each fact. A school entry and a caregiver's recollection can disagree without either being deliberately false; one may record distribution while the other describes administration.
In a fictional tablet-count example, a household reports 20 tablets from one source and 10 from another. Five remain at review. Thirty received minus five remaining equals 25 tablets no longer in the available packs. It does not prove that this patient swallowed 25 tablets: losses, sharing, discarded tablets or an incomplete starting count may explain part of the difference.
Keep an uncertain deworming date as a range or unresolved entry instead of assigning the date of a public campaign. A caregiver remembering 'before the school holiday' has supplied a useful clue, not a confirmed administration date. Staff should route uncertainty to the clinician rather than automatically repeating a medicine.
Discuss practical barriers with neutral questions. A caregiver may have misunderstood the measure, found the taste difficult, lost a bottle or been unable to attend collection. Record the actual obstacle so the clinician can respond to it. An 'irregular' badge without an explanation does not support a useful decision.
A birthday or a new pregnancy can make an old reference card inappropriate, but it does not authorise staff to create a replacement regimen. At the next review, present the current context alongside the old plan and ask the clinician to make the transition explicit.
For antenatal care, identify the pregnancy episode, source of gestational dating, existing supplements and the provider responsible for medicine decisions. Keep an old postpartum entry attached to its original episode. Copying it forward can make a historical course appear current.
At a referral, send the known product and use history, not merely 'on IFA'. If the receiving service changes instructions, retain the effective date and reason where provided, then reconcile the patient-facing copy. Do not leave two equally prominent calendars without explaining which plan applies.
Ask about the next realistic contact point: school distribution, an anganwadi visit, ANC review or the private clinic. This is particularly useful when a family moves between villages or care providers. The record should support continuity without assuming that a person will return to the same dispensing location.
After the clinician resolves the overlap, create a concise plan in the patient's preferred language. It should identify the actual product, the clinician-authorised instructions, the start or change date, the next review and the route for questions. This guide intentionally leaves the dose and timing fields for the responsible clinician.
Separate medicine instructions from a collection appointment. A date for picking up another bottle is not necessarily the date a treatment changes. Likewise, a blood-test booking does not establish that a result has been reviewed or that the current plan has been renewed.
Ask the caregiver to explain which pack they will use and what they will do with a conflicting old sheet. The aim is to reveal ambiguity before the family leaves. A yes/no question such as 'understood?' is less informative than an explanation using the actual containers.
Where more than one adult gives medicines, agree how they will record administrations without exposing unrelated sensitive information. A shared household record can be helpful, but it must identify the correct person and current product rather than use an anonymous tick grid.
Give each clinic reference card an owner, source version and review date. A visible date should represent an actual review of the relevant content, not the day the file was copied. When a programme changes, identify which beneficiary groups and existing instructions need reassessment rather than changing every patient calendar in bulk.
Test the card with contrasting fictional records: a child with an uncertain school dose, a patient with two differently labelled iron products and a pregnant patient transferring care. A useful card helps the team expose the differences; it does not collapse them into one answer.
Review unresolved discrepancies at handover. Record the person who will obtain the missing evidence and the clinician responsible for deciding what happens meanwhile. The team should be able to distinguish 'awaiting pack identification' from 'new instructions agreed' without reopening every attachment.
A parent brings a school supply note and a private prescription, both described at reception as an iron course. The packs have different labels, and the parent cannot say whether the private prescription replaced the school plan. Staff record both products, the known distribution dates and the actual-use account. The clinician reconciles the instructions and identifies one current plan. The older note remains in the history with its original purpose; it is not silently deleted or counted as a second active course.
Use these prompts in your clinic’s own notes. Record the result, responsible person and next action for each item.
No. Record the purpose and source of each plan. Programme supply and individual treatment may overlap, but a clinician must reconcile the person's context and current instructions before treating them as the same course or as additional courses.
Colour alone is insufficient. Use a legible pack or authoritative supply record to verify ingredients, strength and form. Preserve an uncertain colour-based description as reported history rather than converting it into a prescription.
Record the uncertainty and seek the relevant school, programme or clinical record where feasible. Do not invent a date from the campaign calendar or automatically repeat a dose. The clinician should decide how the uncertainty affects the plan.
It shows a stock difference under stated assumptions. It cannot by itself distinguish administration from loss, sharing, disposal or an incomplete starting count. Keep reported use and physical quantities separate.
Check the current official programme guidance and the relevant beneficiary group before adopting a card. NHM's directory lists a 2026 update alongside earlier material. Record what was actually reviewed and obtain clinician approval for the patient instructions.
Updated on . This is a record-reconciliation guide. It does not provide an IFA or albendazole dose, eligibility rule or treatment schedule. No independent clinical or legal review is claimed.
Official Indian directory accessed 25 October 2026. It lists the 2026 operational guidelines alongside older documents. The new 33 MB guideline was not fully retrieved; this article does not reproduce its medicine schedules.
Compare medicine strips, discharge papers and reported use with a three-source case, Hindi intake question and discrepancy handover.
Build an ANC record around the current pregnancy, dated dating evidence, actual test completion and accepted responsibility for risk review and referral.
Document the reason for IV iron, the actual product, administration, observation and follow-up without treating every low haemoglobin alike.
Use fictional school and ANC records to see whether the clinic workflow preserves product evidence, conflicting instructions and an attributable reconciliation decision.
Request a clinic demo